Condition: Clinically Significant Prostate Cancer · Sponsor: Xijing Hospital
The aim of the present study is to investigate a plasma exosome RNA signature to diagnose clinically significant prostate cancer.
This description comes directly from the study's public registry record.
Jianhua Jiao, MD. · +86 029 84771062 · 1531769428@qq.com
Always discuss trial participation with your own doctor first.
| Northwestern Memorial Hospital | Chicago, Illinois, United States | Recruiting |
| The First Hospital of Lanzhou University | Lanzhou, Gansu, China | Recruiting |
| General Hospital of Ningxia Medical University | Yinchuan, Ningxia, China | Recruiting |
| Qinghai University Affiliated Hospital | Xining, Qinghai, China | Recruiting |
| Weinan Central Hospital | Weinan, Shaanxi, China | Recruiting |
| Shaanxi Provincial People's Hospital | Xi'an, Shaanxi, China | Recruiting |
| Xijing 986 Hospital | Xi'an, Shaanxi, China | Recruiting |
| The Second Affiliated Hospital of Shaanxi University of Chinese Medicine | Xianyang, Shaanxi, China | Recruiting |
| Yan'an University Affiliated Hospital | Yan’an, Shaanxi, China | Recruiting |
| Xijing Hospital | Xi'an, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07492927